We are live on ! Find out more
VNA

Valley National Advisers Portfolio holdings

AUM $900M
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+5.17%
1 Year Est. Return
+31.19%
3 Year Est. Return
+79.01%
5 Year Est. Return
+84.11%
10 Year Est. Return
+235%
AUM
$548M
AUM Growth
+$35.9M
Cap. Flow
+$11.4M
Cap. Flow %
2.08%
Top 10 Hldgs %
37.04%
Holding
959
New
68
Increased
234
Reduced
111
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 10.01%
2 Healthcare 7.47%
3 Financials 7.21%
4 Industrials 5.93%
5 Communication Services 4.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHA icon
26
Schwab U.S Small- Cap ETF
SCHA
$23.2B
$3.97M 0.72%
152,304
+9,980
+7% +$255K
UNH icon
27
UnitedHealth
UNH
$372B
$3.78M 0.69%
9,441
+32
+0.3% +$12.8K
GILD icon
28
Gilead Sciences
GILD
$162B
$3.71M 0.68%
53,862
+14,706
+38% +$982K
SCHC icon
29
Schwab International Small-Cap Equity ETF
SCHC
$5.61B
$3.11M 0.57%
74,867
+14,501
+24% +$605K
ARKG icon
30
ARK Genomic Revolution ETF
ARKG
$1.67B
$3.01M 0.55%
32,588
+3,202
+11% +$272K
COF icon
31
Capital One
COF
$136B
$2.99M 0.55%
19,354
-438
-2% -$66.1K
MCD icon
32
McDonald's
MCD
$195B
$2.95M 0.54%
12,772
-158
-1% -$36.8K
CVS icon
33
CVS Health
CVS
$125B
$2.92M 0.53%
34,964
+26
+0.1% +$2.13K
EMR icon
34
Emerson Electric
EMR
$91.8B
$2.91M 0.53%
30,266
+224
+0.7% +$21.1K
JPM icon
35
JPMorgan Chase
JPM
$960B
$2.89M 0.53%
18,598
-172
-0.9% -$27K
PFE icon
36
Pfizer
PFE
$145B
$2.87M 0.52%
73,198
+56
+0.1% +$2.18K
NVO
37
Novo Nordisk
NVO
$200B
$2.84M 0.52%
67,814
+236
+0.3% +$9.15K
TFC icon
38
Truist Financial
TFC
$64.8B
$2.82M 0.52%
50,821
+7,207
+17% +$423K
MSM icon
39
MSC Industrial Direct
MSM
$7.18B
$2.79M 0.51%
31,137
-371
-1% -$33.9K
BDX icon
40
Becton Dickinson
BDX
$46.7B
$2.78M 0.51%
11,707
+8
+0.1% +$1.92K
IUSB icon
41
iShares Core Universal USD Bond ETF
IUSB
$43.1B
$2.75M 0.5%
51,376
+5,777
+13% +$307K
PEP icon
42
PepsiCo
PEP
$189B
$2.73M 0.5%
18,410
-23
-0.1% -$3.35K
NEAR icon
43
iShares Short Maturity Bond ETF
NEAR
$4.85B
$2.72M 0.5%
54,218
+9,238
+21% +$464K
UFOX
44
Defiance Space and Connective Tech ETF
UFOX
$888M
$2.71M 0.49%
71,226
+6,422
+10% +$235K
BLK icon
45
Blackrock
BLK
$176B
$2.66M 0.49%
3,042
-50
-2% -$42.2K
XOM icon
46
ExxonMobil
XOM
$630B
$2.65M 0.48%
42,028
+161
+0.4% +$9.61K
FNDX icon
47
Schwab Fundamental US Large Company Index ETF
FNDX
$27.3B
$2.54M 0.46%
139,167
-1,146
-0.8% -$20.7K
BFIT
48
DELISTED
Global X Funds Global X Health & Wellness ETF
BFIT
$2.43M 0.44%
79,803
+8,055
+11% +$230K
TROW icon
49
T. Rowe Price
TROW
$24.7B
$2.37M 0.43%
11,970
-7
-0.1% -$1.31K
IGV icon
50
iShares Expanded Tech-Software Sector ETF
IGV
$14.4B
$2.37M 0.43%
30,340
+3,110
+11% +$225K

Similar funds

Valley National Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, Valley National Advisers held 959 positions worth $548M, up 7% from $512M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Valley National Advisers's Q2 2021 filing shows 68 new, 234 increased, 111 reduced and 17 closed positions. Its largest new stake was Constellation Brands: 4,671 shares worth $1.09M. The largest sale was Schwab Short-Term US Treasury ETF, an estimated $4.94M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.5% a quarter earlier, followed by Healthcare and Financials.

  • Valley National Advisers's largest Q2 2021 buy was Constellation Brands: 4,671 shares worth $1.09M.
  • Valley National Advisers added most to Schwab US Large- Cap ETF in Q2 2021, an estimated $3.25M increase.
  • Valley National Advisers's biggest Q2 2021 reduction was Schwab Short-Term US Treasury ETF, cutting an estimated $4.94M.
  • Valley National Advisers fully exited Oshkosh in Q2 2021, selling an estimated $188K.
  • Valley National Advisers's ten largest holdings make up 37% of its $548M portfolio in Q2 2021.
  • Valley National Advisers opened 68 new positions and closed 17 in Q2 2021.
  • Valley National Advisers's portfolio value rose 7% quarter-over-quarter to $548M.

Based on Valley National Advisers's 13F filing for Q2 2021, filed 2 Aug 2021.